Mount Sinai Medical Student Calls Out Pfizer’s ‘Misleading Omissions’ in this Week’s FDA VRBPAC Meeting on RSV Vaccines
“Here we see the only all-cause outcome reported in MATISSE…in which vaccination unambiguously showed zero benefit in any time point measured…We did not see this data mentioned in Pfizer’s data today…We’re left to wonder whether infants of vaccinated mothers had any overall reduction in risk of severe LRTI [Lower Respiratory Tract Infection] or hospitalization.
In the primary analysis, three cases were withheld from each group that met criteria for severe MA-RLTI…This made the point estimate and confidence interval more favorable to the vaccine product.”
https://twitter.com/thechiefnerd/status/1660346485412700161
@ChiefNerd
